Oscar Health slips on Obamacare fraud crackdown, analyst calls selloff 'overly punitive'

By Reuters News

** Shares of health insurer Oscar Health OSCR.N fall 1.8% to $30.74

** The Trump administration halts Obamacare enrollment for more than 760,000 people it believes are fraudulently enrolled

** Last month, the US Centers for Medicare & Medicaid Services canceled about 315,000 health plans and would review another 419,000 to 450,000 enrollments to verify eligibility

** Baird analysts says CMS' headline is "in line with, if not slightly favorable to, the assumptions contemplated in OSCR's guidance," making today's stock drop "overly punitive"

** OSCR had already flagged about 1 mln potentially unauthorized members, so the roughly 760,000 affected members announced by CMS is lower than initially feared and is seen as a modest positive, Baird says

** CMS says unauthorized enrollments could lead to up to $6.6 bln in improper federal spending in 2026, while the administration says its fraud crackdown could save about $2.2 bln in taxpayer money

** As of last close, stock more than double YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.